NUCIEN PHARMA terminates the planning of major asset restructuring matters
I'm PortAI, I can summarize articles.
NUCIEN PHARMA announced the termination of the significant asset restructuring with Future Pharma. The company had planned to acquire the target asset group of Future Pharma in cash, but after multiple discussions and negotiations, they failed to reach an agreement on the core terms of the transaction. To protect the interests of the company and its shareholders, the parties involved decided to terminate the transaction and signed the "Acquisition Termination Agreement."
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments